Back to the articles list | Back to browse issues page

XML Print

Prevalence and Antimicrobial Susceptibility Profile of Salmonella spp. Isolated from Blood Cultures of Patients with Suspected Enteric Fever at a Specialized Laboratory in North India
Shoaib Mohmad Khan , Umara Amin * , Tamkeen Masoodi , Tariq Miraj , M. I. Qadri , Mudasir Pirzada , Waseem Ahmad Rather
Department of Microbiology, Dr. Qadri’s Hematology Centre & Clinical Laboratory, Srinagar, Jammu & Kashmir, 190010, India
Abstract:   (7 Views)
Introduction: Enteric fever, caused by Salmonella enterica serovars Typhi and Paratyphi A, is a prevalent infection in developing countries. Although highly endemic in India, data on the prevalence and antimicrobial resistance patterns of this pathogen in Kashmir remain scarce. Therefore, this study aimed to determine the prevalence and antimicrobial susceptibility profile of Salmonella isolates from blood cultures of patients with suspected enteric fever. Methods: A total of 970 blood culture samples from patients with suspected enteric fever were processed at Dr. Qadri’s Hematology Centre & Clinical Laboratory, Srinagar, between October 2022 and September 2024. Samples were inoculated into the BacT/ALERT® culture media. Positive cultures were subcultured on standard agar plates, and the resulting isolates were identified and subjected to antimicrobial susceptibility testing using the VITEK® 2 system according to the latest Clinical and Laboratory Standards Institute (CLSI) guidelines. Results: Of the 970 blood cultures processed, 37 (3.8%) were positive for Salmonella spp., with 23 (62.2%) isolates identified as S. Typhi and 14 (37.8%) as S. Paratyphi A. All isolates showed 100% susceptibility to cefepime, piperacillin/tazobactam, carbapenems, azithromycin, tetracyclines, co-trimoxazole, and polymyxins. Susceptibility to ceftriaxone and tigecycline was 97.3%. In contrast, susceptibility rates were markedly low for the fluoroquinolones ciprofloxacin (2.7%) and levofloxacin (5.4%). Furthermore, no multidrug-resistant (MDR) isolates were detected in this study. Conclusions: This study demonstrates that S. enterica remains a significant cause of bloodstream infections in this resource-limited setting. However, the high prevalence of fluoroquinolone resistance, despite the absence of MDR strains, represents the primary therapeutic challenge in managing these infections. Therefore, extensive surveillance, enhanced diagnostics, and treatment protocols guided by antimicrobial susceptibility testing (AST) reports are crucial to optimize patient outcomes and combat emerging resistance in the region.
Keywords: Antimicrobial resistance, Salmonella, Fluoroquinolone resistance, North India, Minimum inhibitory concentration
     
Type of Study: Original article | Subject: Infectious diseases and public health
Received: 2025/04/13 | Accepted: 2025/09/10
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.